Actively Recruiting
Comparison of Efficacy of Metoclopramide , Promethazine and Prochloroperazine in the Treatment of Vertigo.
Led by Oman Medical Speciality Board · Updated on 2024-12-16
90
Participants Needed
1
Research Sites
151 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Background: Vertigo as acute symptom seem to be one of most common presentation in ED, can be treated in ED with multiple medication . Objective: This study aimed to compare the therapeutic efficacy of metoclopramide, promethazine and prochloroperazine in patients presenting with signs and symptoms suggestive of acute peripheral vertigo to the ED . Methods: A 3-arm multi-center, randomized, triple-blind, controlled study comparing three treatments for acute vertigo in three medical centers : AlNahdha hospital Oman , Sohar Hospital Oman and AFH hospital Oman. Oman From February 2022 to August 2024.
CONDITIONS
Official Title
Comparison of Efficacy of Metoclopramide , Promethazine and Prochloroperazine in the Treatment of Vertigo.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Acute peripheral vertigo with nausea or vomiting and visual analog scale score greater than 5 during the emergency visit
- Onset of vertigo symptoms within 3 days
- Age between 18 and 60 years
You will not qualify if you...
- Age over 60 years
- Any organic brain disease such as malignancy with brain metastasis
- History of epilepsy
- Pregnancy
- Dementia or Parkinson's disease
- Abnormal vital signs
- Known allergy to study drugs
- Undergoing chemotherapy or radiotherapy
- Mechanical bowel obstruction, perforation, or gastrointestinal bleeding
- Unable to understand study explanations or outcome measures
- Refusal to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Al Nahdha hospital, AFH and Sohar hospital
Muscat, Oman, 968
Actively Recruiting
Research Team
A
Asma Al Buraiki, MD
CONTACT
S
Suad AlBulushi, MD master
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here